1. Home
  2. LSTA vs TPCS Comparison

LSTA vs TPCS Comparison

Compare LSTA & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • TPCS
  • Stock Information
  • Founded
  • LSTA 1980
  • TPCS 1956
  • Country
  • LSTA United States
  • TPCS United States
  • Employees
  • LSTA N/A
  • TPCS N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • TPCS Metal Fabrications
  • Sector
  • LSTA Health Care
  • TPCS Industrials
  • Exchange
  • LSTA Nasdaq
  • TPCS Nasdaq
  • Market Cap
  • LSTA 31.2M
  • TPCS 31.5M
  • IPO Year
  • LSTA N/A
  • TPCS N/A
  • Fundamental
  • Price
  • LSTA $2.64
  • TPCS $3.14
  • Analyst Decision
  • LSTA Strong Buy
  • TPCS
  • Analyst Count
  • LSTA 1
  • TPCS 0
  • Target Price
  • LSTA $15.00
  • TPCS N/A
  • AVG Volume (30 Days)
  • LSTA 72.4K
  • TPCS 22.2K
  • Earning Date
  • LSTA 02-27-2025
  • TPCS 01-21-2025
  • Dividend Yield
  • LSTA N/A
  • TPCS N/A
  • EPS Growth
  • LSTA N/A
  • TPCS N/A
  • EPS
  • LSTA N/A
  • TPCS N/A
  • Revenue
  • LSTA N/A
  • TPCS $33,182,059.00
  • Revenue This Year
  • LSTA N/A
  • TPCS N/A
  • Revenue Next Year
  • LSTA N/A
  • TPCS N/A
  • P/E Ratio
  • LSTA N/A
  • TPCS N/A
  • Revenue Growth
  • LSTA N/A
  • TPCS 6.44
  • 52 Week Low
  • LSTA $2.19
  • TPCS $2.85
  • 52 Week High
  • LSTA $4.20
  • TPCS $5.95
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 42.17
  • TPCS 43.58
  • Support Level
  • LSTA $2.45
  • TPCS $3.06
  • Resistance Level
  • LSTA $2.74
  • TPCS $3.25
  • Average True Range (ATR)
  • LSTA 0.32
  • TPCS 0.14
  • MACD
  • LSTA -0.05
  • TPCS 0.01
  • Stochastic Oscillator
  • LSTA 16.48
  • TPCS 26.67

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.

Share on Social Networks: